Global Information
회사소개 | 문의 | 비교리스트

세계의 CAR-T세포 치료 시장 : 유형별, 애플리케이션별, 최종사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Car T Cell Therapy Market, by Type, by Application, by End Users, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045532
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,733,000 PDF (Single User License)
US $ 7,000 ₩ 8,919,000 PDF (Multi User License)
US $ 10,000 ₩ 12,742,000 PDF (Enterprise User License)


세계의 CAR-T세포 치료 시장 : 유형별, 애플리케이션별, 최종사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Car T Cell Therapy Market, by Type, by Application, by End Users, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

FDA 승인 제품을 새로운 적응증에 사용하는 연구 및 CAR-T세포 치료를 환자에게 보다 안전한 것으로 하기 위한 방법의 모색 등 CAR-T세포 치료에 관한 연구에 주력하고 있는 것이 시장의 기회 창출에 기여하고 있는 것으로 생각되고 있습니다. 또한 암의 이환율 증가 및 대체 치료의 실패 등이 신기술의 개발을 촉진하는 주요 요인이 되고 있으며, 이것이 예측 기간 중 시장의 성장을 촉진하고 있습니다.

세계의 CAR-T세포 치료 시장에 대해 조사했으며, 시장 전망, 시장 역학, 시장 분석, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적·전제조건

제2장 시장 전망

  • 리포트 설명
    • 시장의 정의와 범위
  • 개요
    • 시장 스냅숏 : 유형별
    • 시장 스냅숏 : 애플리케이션별
    • 시장 스냅숏 : 최종사용자별
    • 시장 스냅숏 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제 및 동향 분석

  • 연구개발 활동
  • CAR-T세포 치료의 응용
  • 영향 분석
  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회
  • 가격 분석
  • 테스트의 비용
  • 주요 개발
  • 전략적 협업과 계약
  • 규제 시나리오
  • PEST 분석

제4장 세계의 CAR-T세포 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • COVID-19 역학
  • 수요와 공급 분석
  • 주요 발전

제5장 세계의 CAR-T세포 치료 시장 : 유형별(100만 달러)(2017-2028년)

  • 서론
  • Abecma
  • Breyanzi
  • Kymriah
  • Tecartus
  • Yescarta

제6장 세계의 CAR-T세포 치료 시장 : 애플리케이션별(100만 달러)(2017-2028년)

  • 서론
  • 림프종
  • 기타

제7장 세계의 CAR-T세포 치료 시장 : 최종사용자별(100만 달러)(2017-2028년)

  • 서론
  • 병원
  • 전문 클리닉
  • 기타

제8장 세계의 CAR-T세포 치료 시장 : 지역별(100만 달러)(2017-2028년)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 구도

  • 히트맵 분석
  • 시장 점유율 분석
    • Novartis AG.
    • McKinsey & Company
    • Bristol-Myers Squibb Company
    • Kite Pharma
    • Gilead Sciences, Inc.
    • Amgen Inc.
    • Juno Therapeutics
    • Eli Lilly and Company
    • Sorrento Therapeutics, Inc
  • 애널리스트의 견해

제10장 섹션

KSA 22.02.04

Chimeric antigen receptor (CAR) T-cell therapy is a type of immunotherapy that modifies a patient's immune system so it is more effective at finding and destroying cancer cells. CAR T-cell therapy helps T cells to focus their attention toward a substance in body which is harmful called an antigen. In the manufacturing of CAR T cells, a protein is added to the T cell's surface to help them achieve this focus. This protein is called a chimeric antigen receptor. Cancer cells are known to hide from the normal immune system, but through CAR T-cell therapy, scientists are able to make T cells better equipped to find and kill some cancer cells. CAR T cell therapy involves removing T cells from the blood and introducing a new gene into those cells that enables them to recognize the cancer. Many types of cancer such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL) are treating with car T cell therapy in pediatric and young adults. Initially, U.S. Food and Drug Administration has approved car T cell therapy products for patients with adult B-cell non-Hodgkin's lymphoma. As of March 2021, 5 CAR T-cell drugs have been approved by the U.S. Food and Drug Administration (FDA). As an emerging treatment strategy CAR-T therapy requires exploration to expand its clinical application, and further optimization. A continue focus on research around car T-cell therapy, including studying the use of current FDA-approved products for new indications and finding ways to make CAR T-cell therapy safer for patients is contribute to create opportunity in the market

Market Dynamics

Car T cell therapy becomes a remarkably promising treatment for cancer patients. Increasing incidence of cancer and failure of alternative treatments are some of the major factor that create the development of new technology, which contribute to drive the growth of market over the forecast period

Key features of the study:

  • This report provides an in-depth analysis of the global Car T cell therapy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Car T cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Novartis AG, McKinsey & Company, Bristol-Myers Squibb Company, Kite Pharma, Inc., Gilead Sciences, Inc., Amgen Inc., Juno Therapeutics, Eli Lilly and Company, Fate Therapeutics, Sorrento Therapeutics, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Car T cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global car T cell therapy market.

Detailed Segmentation:

  • Global Car T Cell Therapy Market, By Type :
    • Abecma
    • Breyanzi
    • Kymriah
    • Tecartus
    • Yescarta
  • Global Car T Cell Therapy Market, By Application:
    • Cancer
    • Lymphoma
    • Others
  • Global Car T Cell Therapy Market, By End-user:
    • Hospitals
    • Specialty Clinics
    • Others
  • Global Car T Cell Therapy Market, By Region:
    • North America
      • By Type
      • Abecma
      • Breyanzi
      • Kymriah
      • Tecartus
      • Yescarta
      • By Application
      • Cancer
      • Lymphoma
      • Others
      • By End User
      • Hospitals
      • Specialty Clinics
      • Others
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Type
      • Abecma
      • Breyanzi
      • Kymriah
      • Tecartus
      • Yescarta
      • By Application
      • Cancer
      • Lymphoma
      • Others
      • By End User
      • Hospitals
      • Specialty Clinics
      • Others
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type
      • Abecma
      • Breyanzi
      • Kymriah
      • Tecartus
      • Yescarta
      • By Application
      • Cancer
      • Lymphoma
      • Others
      • By End User
      • Hospitals
      • Specialty Clinics
      • Others
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type
      • Abecma
      • Breyanzi
      • Kymriah
      • Tecartus
      • Yescarta
      • By Application
      • Cancer
      • Lymphoma
      • Others
      • By End User
      • Hospitals
      • Specialty Clinics
      • Others
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type
      • Abecma
      • Breyanzi
      • Kymriah
      • Tecartus
      • Yescarta
      • By Application
      • Cancer
      • Lymphoma
      • Others
      • By End User
      • Hospitals
      • Specialty Clinics
      • Others
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type
      • Abecma
      • Breyanzi
      • Kymriah
      • Tecartus
      • Yescarta
      • By Application
      • Cancer
      • Lymphoma
      • Others
      • By End User
      • Hospitals
      • Specialty Clinics
      • Others
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Novartis AG*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • McKinsey & Company
    • Bristol-Myers Squibb Company
    • Kite Pharma, Inc.
    • Gilead Sciences, Inc.
    • Amgen Inc.
    • Juno Therapeutics
    • Eli Lilly and Company
    • Fate Therapeutics
    • Sorrento Therapeutics, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Research & Development (R&D) Activities
  • Application of Car T Cell Therapy
  • Impact Analysis
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Pricing Analysis
  • Cost of Testing
  • Key Developments
  • Strategic Collaborations & Agreements
  • Regulatory Scenario
  • PEST Analysis

4. Global Car T Cell Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply and Demand Analysis
  • Key Developments

5. Global Car T Cell Therapy Market, By Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Abecma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Breyanzi
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Kymriah
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Tecartus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Yescarta
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Car T Cell Therapy Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Car T Cell Therapy Market, By End User, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Car T Cell Therapy Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2028
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Novartis AG.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • McKinsey & Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Kite Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Gilead Sciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Juno Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Sorrento Therapeutics, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
Back to Top
전화 문의
F A Q